UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature communications, ISSN 2041-1723, 04/2020, Volume 11, Issue 1, pp. 1779 - 1779
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 09/2015, Volume 75, Issue 18, pp. 3728 - 3737
Life Sciences & Biomedicine | Oncology | Science & Technology | User-Computer Interface | Algorithms | Neoplasms - genetics | Humans | Cell Line, Tumor | Databases, Genetic | Gene Expression Profiling | RNA, Long Noncoding - genetics | Software | Internet | Index Medicus | lncRNA expression | cancer genomics | prognostic marker | bioinformatics resource | TCGA
Journal Article
Nature communications, ISSN 2041-1723, 10/2014, Volume 5, Issue 1, pp. 5241 - 5241
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Cell Proliferation | Homeodomain Proteins - metabolism | Humans | Lung Neoplasms - pathology | Male | MicroRNAs - metabolism | Epithelial-Mesenchymal Transition - genetics | Immunity | CD8-Positive T-Lymphocytes | Neoplasm Metastasis | Kruppel-Like Transcription Factors - metabolism | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Gene Targeting | Carcinoma, Non-Small-Cell Lung - genetics | Mice, Inbred C57BL | Immune Tolerance | Databases as Topic | Carcinoma, Non-Small-Cell Lung - immunology | Transcription Factors - metabolism | B7-H1 Antigen - metabolism | Lung Neoplasms - immunology | Phenotype | Animals | Models, Biological | Cell Line, Tumor | MicroRNAs - genetics | Lymphocytes, Tumor-Infiltrating - immunology | Zinc Finger E-box-Binding Homeobox 1 | Index Medicus
Journal Article
4.
Full Text
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
Nature communications, ISSN 2041-1723, 12/2020, Volume 11, Issue 1, pp. 4946 - 4946
Journal Article
Clinical cancer research, ISSN 1078-0432, 10/2017, Volume 23, Issue 20, pp. 6239 - 6254
Life Sciences & Biomedicine | Oncology | Science & Technology | TOR Serine-Threonine Kinases - metabolism | Apoptosis - drug effects | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | Apoptosis - genetics | Drug Resistance, Neoplasm | Lung Neoplasms - pathology | Extracellular Signal-Regulated MAP Kinases - metabolism | Cell Cycle Proteins - antagonists & inhibitors | Small Cell Lung Carcinoma - metabolism | Protein-Tyrosine Kinases - genetics | Ribosomal Protein S6 Kinases, 90-kDa - metabolism | Cell Cycle Proteins - genetics | DNA Damage - genetics | Female | Nuclear Proteins - genetics | Disease Models, Animal | Pyrazoles - pharmacology | DNA Damage - drug effects | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Gene Expression | Cell Cycle Proteins - metabolism | Nuclear Proteins - metabolism | Small Cell Lung Carcinoma - genetics | Pyrimidines - pharmacology | Receptor Protein-Tyrosine Kinases - metabolism | Xenograft Model Antitumor Assays | Small Cell Lung Carcinoma - pathology | Animals | Signal Transduction - drug effects | DNA Repair | Nuclear Proteins - antagonists & inhibitors | Cell Line, Tumor | Mice | Protein Kinase Inhibitors - pharmacology | Protein-Tyrosine Kinases - antagonists & inhibitors | TOR protein | Drugs | Medical research | Small cell lung carcinoma | Downstream effects | CHK1 protein | Lung cancer | DNA damage | Clinical trials | Extracellular signal-regulated kinase | Activation | Drug delivery | DNA repair | Axl protein | Recruitment | Proteins | Signaling | Protein arrays | Inhibitors | Experimental design | Inhibition | Repair | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
Journal Article
Nature biotechnology, ISSN 1087-0156, 2014, Volume 32, Issue 7, pp. 644 - 652
Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Genetic Predisposition to Disease - genetics | Proteome - genetics | Prevalence | Risk Assessment | Humans | Databases, Genetic | Neoplasms - mortality | Neoplasms - classification | Neoplasms - genetics | Genetic Markers - genetics | Survival Analysis | Biomarkers, Tumor - genetics | DNA, Neoplasm - genetics | Genetic Predisposition to Disease - epidemiology | Clinical trials | Genetic aspects | Research | Methods | Proteomics | Cancer | Oncology | Genomics | Medical prognosis | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 01/2013, Volume 19, Issue 1, pp. 279 - 290
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Proto-Oncogene Proteins - antagonists & inhibitors | Recurrence | Reproducibility of Results | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Lung Neoplasms - pathology | Proteome | Gene Expression Profiling | Epithelial-Mesenchymal Transition - genetics | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Drug Resistance, Neoplasm - genetics | Neoplasm Metastasis | Animals | Proteomics | Cell Line, Tumor | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Cluster Analysis | Index Medicus | lung cancer | EGFR inhibition | PI3K inhibition | Axl | EMT
Journal Article
Nature communications, ISSN 2041-1723, 05/2014, Volume 5, Issue 1, pp. 3887 - 3887
Journal Article
Nature communications, ISSN 2041-1723, 12/2020, Volume 11, Issue 1, pp. 4520 - 4520
Subpopulations | Profiling | SHP-1 protein | PD-1 protein | CD8 antigen | Melanoma | Collagens | Lymphocytes T | Ribonucleic acid--RNA | Drug resistance | Metastases | Immunosuppression | Lungs | Lymphocytes | Immunotherapy | Exhaustion | Collagen | PD-L1 protein | Extracellular matrix | CD18 antigen | Tumors | Cancer | Index Medicus
Journal Article
Trends in genetics, ISSN 0168-9525, 05/2020, Volume 36, Issue 5, pp. 318 - 336
Journal Article